ImmunityBio, Inc.

IBRX · XNAS

CIK 1326110fmd_1DD4P1Y9Q6ZTX9D17XDCV2FQ3GManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.